Included In This Lesson
Outline
What is the Generic Name
(EMAPALUMAB-LZSG)
What is the Trade Name for (EMAPALUMAB-LZSG)
GAMIFANT
What is the Indication for (EMAPALUMAB-LZSG)
- 1 INDICATIONS AND USAGE GAMIFANT is indicated for the treatment of adult and pediatric (newborn and older) patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory, recurrent or progressive disease or intolerance with conventional HLH therapy. GAMIFANT is an interferon gamma (IFNγ) blocking antibody indicated for the treatment of adult and pediatric (newborn and older) patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory, recurrent or progressive disease or intolerance with conventional HLH therapy. ( 1 )
View Our Nursing Pharmacology Course
References: https://open.fda.gov/
Other Pharm Resources